Browse the evidence

Biomechanical factors such as muscle length and joint angles during compound exercises can lead to suboptimal activation of specific muscles, necessitating targeted isolation exercises to address these gaps.

Understand that squats and deadlifts don't work every muscle equally. For example, squats don't fully stretch or activate the rectus femoris or hamstrings. Add leg extensions and leg curls to your routine to ensure these muscles get adequate stimulus for growth.

The specific repetition scheme used in Low-Load Resistance Training with Blood Flow Restriction (LL-RT with BFR) does not significantly affect muscle hypertrophy outcomes when compared to High-Load Resistance Training.

You can choose your preferred repetition scheme for BFR training (whether to failure, 15 reps, or 75 reps) without worrying about which is 'best' for muscle growth. Focus on consistency and comfort.

Using external momentum (cheat repetitions) during single-joint upper body resistance training produces muscle hypertrophy equivalent to strict form, despite significantly higher total volume load.

If you are doing single-joint exercises like bicep curls or tricep pushdowns, using controlled momentum (cheat reps) to get more reps or heavier loads will likely build muscle just as well as strict form. You don't need to fear cheat reps for hypertrophy purposes, but be aware that the extra stress goes to other muscles (like shoulders or back) and may increase injury risk over time. Use them strategically to increase volume, but prioritize strict form for joint health if you are prone to injury.

Varying proximity-to-failure (progressively decreasing RIR from 4 to 1) does not enhance short-term muscle strength or hypertrophy compared to consistently training at 1 RIR in resistance-trained individuals.

If you are an experienced lifter, you do not need to vary your proximity to failure week-to-week to get stronger or bigger. Training consistently at 1 Repetition in Reserve (RIR 1) produces the same results as a program that starts easy (RIR 4) and gets harder (RIR 1). However, the varying approach results in lower perceived exertion (RPE) during the easier weeks, which may make the training feel less stressful without sacrificing gains.

Resistance-trained individuals have acceptable baseline accuracy in estimating Repetitions in Reserve (RIR), and this accuracy improves further when using a varying proximity-to-failure protocol (RIR 4-1).

If you are an experienced lifter, you can trust your ability to estimate how many reps you have left in the tank (RIR). You don't need to start from scratch. Using a training program that varies your intensity (starting easier and getting harder) can actually help you get better at estimating RIR, making your training more precise and effective.

Progressive increases in resistance training volume (weekly sets) linearly increase perceptual strain and monotony, but these perceptual metrics do not predict muscle hypertrophy (muscle thickness).

If you are increasing your weekly training sets, expect your perceived strain and monotony to go up. However, do not assume that this increased strain will lead to more muscle growth. The study found no link between how hard you perceive the training to be and actual muscle thickness gains. Focus on managing volume to avoid non-functional overreaching rather than chasing high strain as a proxy for hypertrophy.

Following a 2-week adaptation to ad libitum low-carbohydrate or low-fat diets, consuming an isocaloric meal matching the prior diet's macronutrient profile results in significantly lower postprandial glucose, insulin, and triglycerides on a low-carbohydrate diet compared to a low-fat diet.

If you switch to a low-carb diet for two weeks, your body adapts. When you then eat a meal matching that low-carb style, your blood sugar and insulin spikes are significantly lower than if you had been eating a low-fat diet. This suggests that dietary adaptation to macronutrient composition significantly influences metabolic health markers.

Low-carbohydrate diets induce significantly greater early-phase calorie restriction (approx. 162 kcal/d more) compared to low-fat diets, but this advantage dissipates over time, resulting in no long-term difference in energy intake or weight loss.

If you start a low-carb diet, expect a strong initial drop in hunger and calorie intake, which is normal. However, do not expect this advantage to last forever; your appetite will gradually increase as you lose weight, and your calorie intake will eventually match that of someone on a low-fat diet. Focus on finding a sustainable carbohydrate level you can maintain long-term, rather than relying on the initial 'magic' of strict restriction.

Consumption of an ultra-processed dietary pattern (80% UPFs) induces significant alterations in plasma and urine metabolomic profiles compared to an unprocessed dietary pattern, affecting pathways such as glutamate, bile acid, and fatty acid metabolism.

Even if you match the protein and carbs, eating ultra-processed foods changes your body's internal chemistry differently than whole foods. Look for changes in metabolites related to bile acids and amino acids, which may signal different metabolic stressors.

Selective reduction of dietary fat (but not carbohydrate) in adults with obesity decreases striatal dopamine D2/3 receptor binding potential and neural activity to food cues, leading to increased consumption of hyperpalatable foods high in both fat and carbohydrate.

If you are trying to lose weight by cutting fat, be aware that your brain may biologically respond by increasing the 'reward signal' (dopamine) for high-fat, high-carb foods. This doesn't mean you lack willpower; it means your brain is signaling a stronger desire for those specific foods. To counter this, you might need to be extra mindful of hyperpalatable foods (high sugar + high fat) when following a low-fat diet, as your brain may be primed to seek them out more aggressively than if you had restricted carbohydrates instead.

Consuming an unprocessed diet reduces energy intake because participants preferentially select low-energy-dense components (fruits/vegetables) to meet micronutrient requirements, a behavior termed 'micronutrient deleveraging' that limits total caloric intake despite larger meal mass.

To manage energy intake without counting calories, prioritize unprocessed foods that are rich in micronutrients, such as fruits and vegetables. Your body may naturally limit your calorie intake if it prioritizes meeting its micronutrient needs, a process the authors call 'micronutrient deleveraging.' By choosing these foods, you may consume larger volumes of food with fewer calories, satisfying your nutritional requirements without overconsuming energy.

Consuming at least one serving of fatty fish per week is associated with a significantly lower risk of death from ischemic heart disease in adults aged 65 and older.

If you are 65 or older, aim to eat at least one serving of fatty fish (like salmon or mackerin) every week. This specific habit is linked to a significantly lower risk of dying from heart disease in older adults. Avoid frying the fish, as that preparation method does not offer the same protective benefits.

Early weight loss trajectory (first 14 days) and recording frequency can predict long-term weight loss patterns, with shallow initial loss and infrequent logging predicting a 'plateau-then-increase' pattern.

Track your weight daily for the first two weeks. If you aren't losing weight or are skipping logs, you are statistically likely to hit a plateau and regain weight later. Use this early data to adjust your habits immediately rather than waiting months to see if it works.

Adopting a low-inflammatory dietary pattern during a behavioral weight loss intervention significantly improves psychological health outcomes, including reduced depression and stress, independent of the amount of weight lost.

If you are trying to lose weight, pay attention to how inflammatory your diet is, not just how many calories you cut. Choosing foods that reduce inflammation (like vegetables, fruits, and healthy fats) can significantly lower your stress and depression levels and improve your overall quality of life, even if the scale doesn't move as fast as you'd like. This mental health benefit is distinct from the physical act of losing weight itself.

Perceived success in weight loss maintenance is a stronger predictor of satisfaction and continued physical activity engagement than quantitative weight loss metrics alone.

Don't just focus on the scale. If you don't *feel* like you've succeeded, you're less likely to stay active and satisfied, even if you've lost weight. Align your goals with how you want to feel and function, not just a percentage of weight loss.

Replacing saturated fats with polyunsaturated fats reduces cardiovascular disease risk, whereas replacing saturated fats with refined carbohydrates increases myocardial infarction risk.

To protect your heart, focus on what you swap out. If you reduce saturated fats (like butter or fatty meats), replace them with unsaturated fats (like olive oil, nuts, or fish), not refined carbs (like white bread or sugar). Swapping fat for refined carbs may actually increase your risk of heart attack.

GLP-1 receptor agonists (specifically high-dose liraglutide) prevent the progression from prediabetes to type 2 diabetes in obese individuals.

If you have prediabetes and are overweight, talk to your doctor about GLP-1 medications like liraglutide. They can significantly reduce your risk of developing full-blown type 2 diabetes.

Incretin-based treatments (semaglutide, dulaglutide) are effective and safe in adolescents with obesity or type 2 diabetes.

For teenagers with obesity or type 2 diabetes, weekly injections of semaglutide or dulaglutide can significantly improve weight and blood sugar control. Side effects like nausea are common but usually mild and go away quickly.

Shorter duration of hypertension history is an independent predictor of hypertension remission following Roux-en-Y gastric bypass surgery, with each additional year of history decreasing the odds of remission by approximately 15%.

If you are considering bariatric surgery to get off blood pressure medication, the length of time you have had high blood pressure matters. The study shows that for every year you wait, your chances of successfully stopping medication drop by about 15%. This suggests that addressing hypertension early, or seeking surgical options sooner rather than later, offers the best chance for remission.

Continuous Glucose Monitoring (CGM) and Flash Glucose Monitoring systems improve glycemic control and reduce hypoglycemia risk in patients with Type 2 Diabetes, particularly those on insulin therapy.

If you have Type 2 Diabetes and are on insulin, ask your doctor about Continuous Glucose Monitoring (CGM) or Flash Glucose Monitoring systems. These devices provide real-time data on your blood sugar levels and trends, helping you and your doctor adjust your insulin doses more precisely and safely, reducing the risk of dangerous lows.

GLP-1 receptor agonists (Liraglutid, Semaglutid) and dual agonists (Tirzepatid) produce significant weight loss (16-20%) and reduce cardiovascular/renal complications in Type 2 Diabetes, but their long-term efficacy and cost-effectiveness remain unproven.

If lifestyle changes are insufficient, GLP-1 drugs like Semaglutid offer significant weight loss (up to 20%) and heart/kidney benefits, especially for diabetics. However, they are expensive, require injections, and likely need to be taken indefinitely to maintain weight loss. Discuss cost and long-term commitment with your doctor.

SGLT-2 inhibitors, orlistat, phentermine/topiramate, metformin, tirzepatide, and Gelesis100 demonstrate varying degrees of efficacy in weight management, with SGLT-2 inhibitors showing mild but significant weight loss in non-diabetic obese patients.

Several other medications besides GLP-1 agonists can help with weight loss, including SGLT-2 inhibitors, orlistat, phentermine/topiramate, metformin, tirzepatide, and Gelesis100. Their effectiveness varies, with some showing significant weight loss and others showing mild but significant benefits. These options provide additional choices for patients who may not be candidates for or respond poorly to GLP-1 agonists.

SGLT2 inhibitors (specifically enavogliflozin and sotagliflozin) provide superior glycemic control and cardiovascular/renal benefits compared to placebo or standard care in patients with type 2 diabetes, with sotagliflozin specifically indicated for heart failure.

If you have type 2 diabetes and heart or kidney issues, ask your doctor about SGLT2 inhibitors like sotagliflozin or enavogliflozin. These oral drugs are now prioritized in guidelines because they protect your heart and kidneys while lowering blood sugar.

GLP-1 receptor agonists (specifically semaglutide) produce substantial, sustained weight loss and improve health status in patients with heart failure with preserved ejection fraction (HFpEF).

For patients with HFpEF and obesity, GLP-1 agonists like semaglutide are a potent tool for weight loss and improving heart function. This treatment, combined with dietary advice, can lead to significant health improvements. Discuss this option with your cardiologist, especially if other weight loss methods have been difficult to sustain.